Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

Metadata

Authors/Creators:	Palmieri, C Stein, RC Liu, X Hudson, E Nicholas, H Sasano, H Guestini, F Holcombe, C Barrett, S Kenny, L Reed, S https://orcid.org/0000-0003-1099-9615 Lim, A Hayward, L Howell, S Coombes, RC
Commentary on:	Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806
Copyright, Publisher and Additional Information:	© Springer Science+Business Media, LLC 2017.
Dates:	Accepted: 25 October 2017 Published (online): 25 October 2017 Published: January 2018
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	23 Jan 2018 12:12
Last Modified:	26 Jul 2018 13:05
Status:	Published
Publisher:	Springer Verlag
Identification Number:	https://doi.org/10.1007/s10549-017-4539-3

Palmieri, C, Stein, RC, Liu, X, Hudson, E, Nicholas, H, Sasano, H, Guestini, F, Holcombe, C, Barrett, S, Kenny, L, Reed, S, Lim, A, Hayward, L, Howell, S and Coombes, RC IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. (deposited 23 Jan 2018 12:00)
- Palmieri, C, Stein, RC, Liu, X, Hudson, E, Nicholas, H, Sasano, H, Guestini, F, Holcombe, C, Barrett, S, Kenny, L, Reed, S, Lim, A, Hayward, L, Howell, S and Coombes, RC Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. (deposited 23 Jan 2018 12:12) [Currently Displayed]

CORE (COnnecting REpositories)